Evidence map›Paper›PMID 31420595›Full record

ArticleJournal of human genetics2019

A de novo variant in RAC3 causes severe global developmental delay and a middle interhemispheric variant of holoprosencephaly.

Takuya Hiraide, Hikari Kaba Yasui, Mitsuhiro Kato, Mitsuko Nakashima, Hirotomo Saitsu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. An unusual presentation of de novo RAC3 variation in prenatal diagnosis.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Article
  5. Review
  6. Dispensable role of Rac1 and Rac3 after cochlear hair cell specification.Journal of molecular medicine (Berlin, Germany) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Takuya HiraideDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hikari Kaba YasuiDepartment of Neurology, Kanagawa Children's Medical Center, Tokyo, Japan.
Mitsuhiro KatoDepartment of Pediatrics, Showa University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0003-1485-8553
Mitsuko NakashimaDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan. mnakashi@hama-med.ac.jp.ORCID http://orcid.org/0000-0001-7941-1774
Hirotomo SaitsuDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan.ORCID http://orcid.org/0000-0003-0723-0960
Hamamatsu University School of Medicine · JPHamamatsu University · JPKanagawa Children's Medical Center · JPShowa University · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP18ek0109297MEXT | Japan Society for the Promotion of Science (JSPS) JP16H05160Ministry of Health, Labour and Welfare (Ministry of Health, Labour and Welfare, Japan) H29- nanchitou-ippan-025
6 · The paper itself

Abstract

RAC3 is a member of the Rho GTPases family, which has important regulatory functions in aspects of neuronal morphogenesis. Rho GTPases show a conformational change in two regions (switch I and II) through GTP binding, which provides a platform for selective interactions with functionally diverse proteins. Missense variants in the switch I and II regions of RAC3 were recently suggested to cause severe intellectual disability and brain malformations. Here, we report an individual with a novel de novo RAC3 variant (c.101 C>G, p.(Pro34Arg)), which substitutes for an evolutionarily conserved amino acid within the switch I region. The patient showed severe global developmental delay, intellectual disability, epilepsy, and laryngeal dystonia. An imaging study revealed characteristic brain dysplasia, including coexistence of the middle interhemispheric variant of holoprosencephaly and brainstem dysmorphism. Our study supports that RAC3 variants cause syndromic neurodevelopmental disorders and brain structural abnormality, and expands the phenotypic spectrum of RAC3-related disorders.

Indexed as

Amino Acid SubstitutionChildChild, PreschoolConserved SequenceDevelopmental DisabilitiesGenetic Predisposition to DiseaseHoloprosencephalyHumansInfant, NewbornIntellectual DisabilityMaleMutation, MissensePhenotyperac GTP-Binding ProteinsRAC3 protein, humanrac GTP-Binding Proteins

Identifiers

PMID31420595
OpenAlexW2968230235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.